🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

VAR 200 and IC 100

Zy Versa Therapeutics, Inc. is a clinical stage biopharmaceutical company developing products for renal and inflammatory diseases, including VAR 200 for focal segmental glomerulosclerosis and related conditions, and IC 100 as an ASC inhibitor for inflammatory diseases.

Tags: biopharmaceutical, cholesterol efflux mediator, inflammasome ASC inhibitor, inflammatory diseases, renal diseases

Website

About | Vision/Values | Leadership | About | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About | About

Symbol: ZVSA

Recent Price: $1.07

Industry: Biotechnology

CEO: Mr. Stephen C. Glover

Sector: Healthcare

Employees: 7

Address: 2200 N. Commerce Parkway, Weston, FL 33326

Phone: 754 231 1688

Leadership

  • Stephen C. Glover, Chairman of the Board at Ambrx Biopharma
  • Pablo A. Guzman, MD, FACC, Board of Directors member
  • Karen Cashmere, Board of Directors member
  • Peter Wolfe, Board of Directors member
  • Robert (Rob) G. Finizio, Executive Director of PleoPharma
  • GREGORY G. FREITAG, JD, CPA, Principal of FreiMc
  • Minchul Park, Ph.D, Chief Executive Officer, and Director of Curebio Therapeutics, Adjunct Professor, Korea University, Department of Pharmacy
  • JAMES SAPIRSTEIN, Chairman, Chief Executive Officer and President of First Wave Biopharma
  • N/A, N/A

Last updated: 2024-12-31